Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 83

1.

Efficacy of Fecal Microbiota Transplantation for Clostridium difficile Infection in Children.

Nicholson MR, Mitchell PD, Alexander E, Ballal S, Bartlett M, Becker P, Davidovics Z, Docktor M, Dole M, Felix G, Gisser J, Hourigan SK, Jensen MK, Kaplan JL, Kelsen J, Kennedy M, Khanna S, Knackstedt E, Leier M, Lewis J, Lodarek A, Michail S, Oliva-Hemker M, Patton T, Queliza K, Russell GH, Singh N, Solomon A, Suskind DL, Werlin S, Kellermayer R, Kahn SA.

Clin Gastroenterol Hepatol. 2019 Apr 19. pii: S1542-3565(19)30427-6. doi: 10.1016/j.cgh.2019.04.037. [Epub ahead of print]

PMID:
31009795
2.

Clinical and biological predictors of response to standardised paediatric colitis therapy (PROTECT): a multicentre inception cohort study.

Hyams JS, Davis Thomas S, Gotman N, Haberman Y, Karns R, Schirmer M, Mo A, Mack DR, Boyle B, Griffiths AM, LeLeiko NS, Sauer CG, Keljo DJ, Markowitz J, Baker SS, Rosh J, Baldassano RN, Patel A, Pfefferkorn M, Otley A, Heyman M, Noe J, Oliva-Hemker M, Rufo PA, Strople J, Ziring D, Guthery SL, Sudel B, Benkov K, Wali P, Moulton D, Evans J, Kappelman MD, Marquis MA, Sylvester FA, Collins MH, Venkateswaran S, Dubinsky M, Tangpricha V, Spada KL, Saul B, Wang J, Serrano J, Hommel K, Marigorta UM, Gibson G, Xavier RJ, Kugathasan S, Walters T, Denson LA.

Lancet. 2019 Apr 27;393(10182):1708-1720. doi: 10.1016/S0140-6736(18)32592-3. Epub 2019 Mar 29.

PMID:
30935734
3.

Variation in Care in the Management of Children With Crohn's Disease: Data From a Multicenter Inception Cohort Study.

Krishnakumar C, Ballengee CR, Liu C, Kim MO, Baker SS, Baldassano RN, Cohen SA, Crandall WV, Denson LA, Dubinsky MC, Evans J, Gokhale R, Griffiths A, Guthery SL, Oliva-Hemker M, Heyman MB, Keljo D, Kellermayer R, Leleiko NS, Mack DR, Markowitz JF, Moulton DE, Noe JD, Otley AR, Patel AS, Pfefferkorn M, Rabizadeh S, Rosh JR, Snapper S, Walters TD, Ziring D, Mondal K, Kappelman MD, Hyams JS, Kugathasan S.

Inflamm Bowel Dis. 2019 Jun 18;25(7):1208-1217. doi: 10.1093/ibd/izy363.

PMID:
30601983
4.

Utilizing Information Technology to Improve Influenza Vaccination in Pediatric Patients With Inflammatory Bowel Disease.

Shores D, Wilson L, Oliva-Hemker M.

Gastroenterol Nurs. 2019 Jul/Aug;42(4):370-374. doi: 10.1097/SGA.0000000000000321.

PMID:
30585911
5.

Age-of-diagnosis dependent ileal immune intensification and reduced alpha-defensin in older versus younger pediatric Crohn Disease patients despite already established dysbiosis.

Haberman Y, Schirmer M, Dexheimer PJ, Karns R, Braun T, Kim MO, Walters TD, Baldassano RN, Noe JD, Rosh J, Markowitz J, Crandall WV, Mack DR, Griffiths AM, Heyman MB, Baker SS, Kellermayer R, Moulton D, Patel AS, Gulati AS, Steiner SJ, LeLeiko N, Otley A, Oliva-Hemker M, Ziring D, Kirschner BS, Keljo DJ, Guthery SL, Cohen SA, Snapper S, Evans J, Dubinsky M, Aronow B, Hyams JS, Kugathasan S, Huttenhower C, Xavier RJ, Denson LA.

Mucosal Immunol. 2019 Mar;12(2):491-502. doi: 10.1038/s41385-018-0114-4. Epub 2018 Dec 12.

6.

Decreased Fecal Bacterial Diversity and Altered Microbiome in Children Colonized With Clostridium difficile.

Chen LA, Hourigan SK, Grigoryan Z, Gao Z, Clemente JC, Rideout JR, Chirumamilla S, Rabidazeh S, Saeed S, Elson CO, Oliva-Hemker M, Blaser MJ, Sears CL.

J Pediatr Gastroenterol Nutr. 2019 Apr;68(4):502-508. doi: 10.1097/MPG.0000000000002210.

PMID:
30540709
7.

Compositional and Temporal Changes in the Gut Microbiome of Pediatric Ulcerative Colitis Patients Are Linked to Disease Course.

Schirmer M, Denson L, Vlamakis H, Franzosa EA, Thomas S, Gotman NM, Rufo P, Baker SS, Sauer C, Markowitz J, Pfefferkorn M, Oliva-Hemker M, Rosh J, Otley A, Boyle B, Mack D, Baldassano R, Keljo D, LeLeiko N, Heyman M, Griffiths A, Patel AS, Noe J, Kugathasan S, Walters T, Huttenhower C, Hyams J, Xavier RJ.

Cell Host Microbe. 2018 Oct 10;24(4):600-610.e4. doi: 10.1016/j.chom.2018.09.009.

PMID:
30308161
8.

The Effect of Early-Life Environmental Exposures on Disease Phenotype and Clinical Course of Crohn's Disease in Children.

Lindoso L, Mondal K, Venkateswaran S, Somineni HK, Ballengee C, Walters TD, Griffiths A, Noe JD, Crandall W, Snapper S, Rabizadeh S, Rosh JR, LeLeiko N, Guthery S, Mack D, Kellermayer R, Gulati AS, Pfefferkorn MD, Moulton DE, Keljo D, Cohen S, Oliva-Hemker M, Heyman MB, Otley A, Baker SS, Evans JS, Kirschner BS, Patel AS, Ziring D, Stephens MC, Baldassano R, Dubinsky MC, Markowitz J, Denson LA, Hyams J, Kugathasan S, Ananthakrishnan AN.

Am J Gastroenterol. 2018 Oct;113(10):1524-1529. doi: 10.1038/s41395-018-0239-9. Epub 2018 Sep 28.

PMID:
30267029
9.

Malnutrition increases the risk of 30-day complications after surgery in pediatric patients with Crohn disease.

Ladd MR, Garcia AV, Leeds IL, Haney C, Oliva-Hemker MM, Alaish S, Boss E, Rhee DS.

J Pediatr Surg. 2018 Nov;53(11):2336-2345. doi: 10.1016/j.jpedsurg.2018.04.026. Epub 2018 Apr 27.

PMID:
29843908
10.

Serologic Reactivity Reflects Clinical Expression of Ulcerative Colitis in Children.

Spencer EA, Davis SM, Mack DR, Boyle BM, Griffiths AM, LeLeiko NS, Sauer CG, Keljo DJ, Markowitz JF, Baker SS, Rosh JR, Baldassano RN, Oliva-Hemker M, Pfefferkorn MD, Otley AR, Heyman MB, Noe JD, Patel AS, Rufo PA; PROTECT Study Group, Alison Marquis M, Walters TD, Collins MH, Kugathasan S, Denson LA, Hyams JS, Dubinsky MC.

Inflamm Bowel Dis. 2018 May 18;24(6):1335-1343. doi: 10.1093/ibd/izy009.

11.

Enhanced Contribution of HLA in Pediatric Onset Ulcerative Colitis.

Venkateswaran S, Prince J, Cutler DJ, Marigorta UM, Okou DT, Prahalad S, Mack D, Boyle B, Walters T, Griffiths A, Sauer CG, LeLeiko N, Keljo D, Markowitz J, Baker SS, Rosh J, Pfefferkorn M, Heyman MB, Patel A, Otley A, Baldassano R, Noe J, Rufo P, Oliva-Hemker M, Davis S, Zwick ME, Gibson G, Denson LA, Hyams J, Kugathasan S.

Inflamm Bowel Dis. 2018 Mar 19;24(4):829-838. doi: 10.1093/ibd/izx084.

12.

Celiac Disease.

Murray JA, Frey MR, Oliva-Hemker M.

Gastroenterology. 2018 Jun;154(8):2005-2008. doi: 10.1053/j.gastro.2017.12.026. Epub 2018 Mar 15. Review. No abstract available.

13.

Biologics Delay Progression of Crohn's Disease, but Not Early Surgery, in Children.

Kerur B, Machan JT, Shapiro JM, Cerezo CS, Markowitz J, Mack DR, Griffiths AM, Otley AR, Pfefferkorn MD, Rosh JR, Keljo DJ, Boyle B, Oliva-Hemker M, Kay MH, Saeed SA, Grossman AB, Sudel B, Kappelman MD, Schaefer M, Tomer G, Bousvaros A, Lerer T, Hyams JS, LeLeiko NS.

Clin Gastroenterol Hepatol. 2018 Sep;16(9):1467-1473. doi: 10.1016/j.cgh.2018.02.027. Epub 2018 Mar 2.

PMID:
29486253
14.

The 2017 Shwachman Award.

Oliva-Hemker M.

J Pediatr Gastroenterol Nutr. 2018 May;66(5):711-712. doi: 10.1097/MPG.0000000000001925. No abstract available.

PMID:
29470282
15.

Long ncRNA Landscape in the Ileum of Treatment-Naive Early-Onset Crohn Disease.

Haberman Y, BenShoshan M, Di Segni A, Dexheimer PJ, Braun T, Weiss B, Walters TD, Baldassano RN, Noe JD, Markowitz J, Rosh J, Heyman MB, Griffiths AM, Crandall WV, Mack DR, Baker SS, Kellermayer R, Patel A, Otley A, Steiner SJ, Gulati AS, Guthery SL, LeLeiko N, Moulton D, Kirschner BS, Snapper S, Avivi C, Barshack I, Oliva-Hemker M, Cohen SA, Keljo DJ, Ziring D, Anikster Y, Aronow B, Hyams JS, Kugathasan S, Denson LA.

Inflamm Bowel Dis. 2018 Jan 18;24(2):346-360. doi: 10.1093/ibd/izx013.

16.

Factors associated with early outcomes following standardised therapy in children with ulcerative colitis (PROTECT): a multicentre inception cohort study.

Hyams JS, Davis S, Mack DR, Boyle B, Griffiths AM, LeLeiko NS, Sauer CG, Keljo DJ, Markowitz J, Baker SS, Rosh J, Baldassano RN, Patel A, Pfefferkorn M, Otley A, Heyman M, Noe J, Oliva-Hemker M, Rufo P, Strople J, Ziring D, Guthery SL, Sudel B, Benkov K, Wali P, Moulton D, Evans J, Kappelman MD, Marquis A, Sylvester FA, Collins MH, Venkateswaran S, Dubinsky M, Tangpricha V, Spada KL, Britt A, Saul B, Gotman N, Wang J, Serrano J, Kugathasan S, Walters T, Denson LA.

Lancet Gastroenterol Hepatol. 2017 Dec;2(12):855-868. doi: 10.1016/S2468-1253(17)30252-2. Epub 2017 Sep 20.

17.

Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study.

Kugathasan S, Denson LA, Walters TD, Kim MO, Marigorta UM, Schirmer M, Mondal K, Liu C, Griffiths A, Noe JD, Crandall WV, Snapper S, Rabizadeh S, Rosh JR, Shapiro JM, Guthery S, Mack DR, Kellermayer R, Kappelman MD, Steiner S, Moulton DE, Keljo D, Cohen S, Oliva-Hemker M, Heyman MB, Otley AR, Baker SS, Evans JS, Kirschner BS, Patel AS, Ziring D, Trapnell BC, Sylvester FA, Stephens MC, Baldassano RN, Markowitz JF, Cho J, Xavier RJ, Huttenhower C, Aronow BJ, Gibson G, Hyams JS, Dubinsky MC.

Lancet. 2017 Apr 29;389(10080):1710-1718. doi: 10.1016/S0140-6736(17)30317-3. Epub 2017 Mar 2.

18.

Fecal microbiota transplantation in children: a brief review.

Hourigan SK, Oliva-Hemker M.

Pediatr Res. 2016 Jul;80(1):2-6. doi: 10.1038/pr.2016.48. Epub 2016 Mar 16. Review.

PMID:
26982451
19.

Clostridium difficile Infection in Pediatric Inflammatory Bowel Disease.

Hourigan SK, Sears CL, Oliva-Hemker M.

Inflamm Bowel Dis. 2016 Apr;22(4):1020-5. doi: 10.1097/MIB.0000000000000666. Review.

20.

Microbiome changes associated with sustained eradication of Clostridium difficile after single faecal microbiota transplantation in children with and without inflammatory bowel disease.

Hourigan SK, Chen LA, Grigoryan Z, Laroche G, Weidner M, Sears CL, Oliva-Hemker M.

Aliment Pharmacol Ther. 2015 Sep;42(6):741-52. doi: 10.1111/apt.13326. Epub 2015 Jul 21.

21.

Clinical Presentation and Five-Year Therapeutic Management of Very Early-Onset Inflammatory Bowel Disease in a Large North American Cohort.

Oliva-Hemker M, Hutfless S, Al Kazzi ES, Lerer T, Mack D, LeLeiko N, Griffiths A, Cabrera J, Otley A, Rick J, Bousvaros A, Rosh J, Grossman A, Saeed S, Kay M, Carvalho R, Keljo D, Pfefferkorn M, Faubion W Jr, Kappelman M, Sudel B, Schaefer ME, Markowitz J, Hyams JS.

J Pediatr. 2015 Sep;167(3):527-32.e1-3. doi: 10.1016/j.jpeds.2015.04.045. Epub 2015 May 15.

PMID:
25982142
22.

Concomitant Use of Immunomodulators Affects the Durability of Infliximab Therapy in Children With Crohn's Disease.

Grossi V, Lerer T, Griffiths A, LeLeiko N, Cabrera J, Otley A, Rick J, Mack D, Bousvaros A, Rosh J, Grossman A, Saeed S, Kay M, Boyle B, Oliva-Hemker M, Keljo D, Pfefferkorn M, Faubion W, Kappelman MD, Sudel B, Markowitz J, Hyams JS.

Clin Gastroenterol Hepatol. 2015 Oct;13(10):1748-56. doi: 10.1016/j.cgh.2015.04.010. Epub 2015 Apr 21.

PMID:
25911120
23.

Retrospective cohort study of methotrexate use in the treatment of pediatric Crohn's disease.

Sunseri W, Hyams JS, Lerer T, Mack DR, Griffiths AM, Otley AR, Rosh JR, Carvalho R, Grossman AB, Cabrera J, Pfefferkorn MD, Rick J, Leleiko NS, Hitch MC, Oliva-Hemker M, Saeed SA, Kappelman M, Markowitz J, Keljo DJ; Pediatric Inflammatory Bowel Disease Collaborative Research Group.

Inflamm Bowel Dis. 2014 Aug;20(8):1341-5. doi: 10.1097/MIB.0000000000000102.

PMID:
24983976
24.

Two single group, prospective, baseline-controlled feeding studies in infants and children with chronic diarrhea fed a hypoallergenic free amino acid-based formula.

Borschel MW, Antonson DL, Murray ND, Oliva-Hemker M, Mattis LE, Kerzner B, Tolia V, Baggs G.

BMC Pediatr. 2014 May 29;14:136. doi: 10.1186/1471-2431-14-136.

25.

Liver enzyme elevations within 3 months of diagnosis of inflammatory bowel disease and likelihood of liver disease.

Goyal A, Hyams JS, Lerer T, Leleiko NS, Otley AR, Griffiths AM, Rosh JR, Cabrera JM, Oliva-Hemker MM, Mack DR, Rick JN, Pfefferkorn MD, Carvalho R, Grossman AB, Hitch MC, Sudel B, Kappelman MD, Saeed SA, Faubion WA, Schaefer ME, Markowitz JF, Keljo DJ; Pediatric Inflammatory Bowel Disease Collaborative Research Group.

J Pediatr Gastroenterol Nutr. 2014 Sep;59(3):321-3. doi: 10.1097/MPG.0000000000000409.

PMID:
24796799
26.

The prevalence of Clostridium difficile infection in pediatric and adult patients with inflammatory bowel disease.

Hourigan SK, Oliva-Hemker M, Hutfless S.

Dig Dis Sci. 2014 Sep;59(9):2222-7. doi: 10.1007/s10620-014-3169-4. Epub 2014 May 1.

PMID:
24788321
27.

Evaluation of a free amino acid-based formula in infants with presumptive food protein-induced proctocolitis.

Borschel MW, Antonson DL, Murray ND, Oliva-Hemker M, Mattis LE, Baggs GE.

SAGE Open Med. 2014 Sep 20;2:2050312114551857. doi: 10.1177/2050312114551857. eCollection 2014.

28.

Increased effectiveness of early therapy with anti-tumor necrosis factor-α vs an immunomodulator in children with Crohn's disease.

Walters TD, Kim MO, Denson LA, Griffiths AM, Dubinsky M, Markowitz J, Baldassano R, Crandall W, Rosh J, Pfefferkorn M, Otley A, Heyman MB, LeLeiko N, Baker S, Guthery SL, Evans J, Ziring D, Kellermayer R, Stephens M, Mack D, Oliva-Hemker M, Patel AS, Kirschner B, Moulton D, Cohen S, Kim S, Liu C, Essers J, Kugathasan S, Hyams JS; PRO-KIIDS Research Group.

Gastroenterology. 2014 Feb;146(2):383-91. doi: 10.1053/j.gastro.2013.10.027. Epub 2013 Oct 23.

PMID:
24162032
29.

Clostridium difficile carriage and serum antitoxin responses in children with inflammatory bowel disease.

Hourigan SK, Chirumamilla SR, Ross T, Golub JE, Rabizadeh S, Saeed SA, Elson CO, Kelly CP, Carroll KC, Oliva-Hemker M, Sears C.

Inflamm Bowel Dis. 2013 Dec;19(13):2744-52. doi: 10.1097/01.MIB.0000435434.53871.36.

PMID:
24145927
30.

TGFβ receptor mutations impose a strong predisposition for human allergic disease.

Frischmeyer-Guerrerio PA, Guerrerio AL, Oswald G, Chichester K, Myers L, Halushka MK, Oliva-Hemker M, Wood RA, Dietz HC.

Sci Transl Med. 2013 Jul 24;5(195):195ra94. doi: 10.1126/scitranslmed.3006448.

31.

Magnet ingestions in children presenting to US emergency departments, 2002-2011.

Abbas MI, Oliva-Hemker M, Choi J, Lustik M, Gilger MA, Noel RA, Schwarz K, Nylund CM.

J Pediatr Gastroenterol Nutr. 2013 Jul;57(1):18-22. doi: 10.1097/MPG.0b013e3182952ee5.

PMID:
23575300
32.

Infliximab for the treatment of pediatric ulcerative colitis.

Bradley GM, Oliva-Hemker M.

Expert Rev Gastroenterol Hepatol. 2012 Dec;6(6):659-65. doi: 10.1586/egh.12.53. Review.

PMID:
23237250
33.

Outcome following aminosalicylate therapy in children newly diagnosed as having ulcerative colitis.

Zeisler B, Lerer T, Markowitz J, Mack D, Griffiths A, Bousvaros A, Keljo D, Rosh J, Evans J, Kappelman M, Otley A, Kay M, Grossman A, Saeed S, Carvalho R, Oliva-Hemker M, Faubion W, Sudel B, Pfefferkorn M, Ashai-Khan F, Leleiko N, Hyams J; Pediatric Inflammatory Bowel Disease Collaborative Research Group.

J Pediatr Gastroenterol Nutr. 2013 Jan;56(1):12-8. doi: 10.1097/MPG.0b013e31826ac41a.

PMID:
22847466
34.

Pediatric ulcerative colitis: current treatment approaches including role of infliximab.

Bradley GM, Oliva-Hemker M.

Biologics. 2012;6:125-34. doi: 10.2147/BTT.S31833. Epub 2012 Jun 5.

35.

Contribution of higher risk genes and European admixture to Crohn's disease in African Americans.

Wang MH, Okazaki T, Kugathasan S, Cho JH, Isaacs KL, Lewis JD, Smoot DT, Valentine JF, Kader HA, Ford JG, Harris ML, Oliva-Hemker M, Cuffari C, Torbenson MS, Duerr RH, Silverberg MS, Rioux JD, Taylor KD, Nguyen GC, Wu Y, Datta LW, Hooker S, Dassopoulos T, Kittles RA, Kao LW, Brant SR.

Inflamm Bowel Dis. 2012 Dec;18(12):2277-87. doi: 10.1002/ibd.22931. Epub 2012 Mar 12.

36.

Nutritional outcomes following gastrostomy in children with cystic fibrosis.

Bradley GM, Carson KA, Leonard AR, Mogayzel PJ Jr, Oliva-Hemker M.

Pediatr Pulmonol. 2012 Aug;47(8):743-8. doi: 10.1002/ppul.22507. Epub 2012 Feb 1.

37.

Budesonide use in pediatric Crohn disease.

Otley A, LeLeiko N, Langton C, Lerer T, Mack D, Evans J, Pfefferkorn M, Carvalho R, Rosh J, Griffiths A, Oliva-Hemker M, Kay M, Bousvaros A, Stephens M, Samson C, Grossman A, Keljo D, Markowitz J, Hyams J; Pediatric IBD Collaborative Research Group.

J Pediatr Gastroenterol Nutr. 2012 Aug;55(2):200-4. doi: 10.1097/MPG.0b013e31824a09c2.

PMID:
22258289
38.

MR enterography findings of inflammatory bowel disease in pediatric patients.

Chalian M, Ozturk A, Oliva-Hemker M, Pryde S, Huisman TA.

AJR Am J Roentgenol. 2011 Jun;196(6):W810-6. doi: 10.2214/AJR.10.5474. Review.

PMID:
21606274
39.

Annual update of pediatric digestive diseases.

Oliva-Hemker M, Yeung KA, Cuffari C, Scheimann A, Wilson L.

Expert Rev Gastroenterol Hepatol. 2011 Feb;5(1):21-3. doi: 10.1586/egh.10.91.

PMID:
21309668
40.

Outcome following thiopurine use in children with ulcerative colitis: a prospective multicenter registry study.

Hyams JS, Lerer T, Mack D, Bousvaros A, Griffiths A, Rosh J, Otley A, Evans J, Stephens M, Kay M, Keljo D, Pfefferkorn M, Saeed S, Crandall W, Michail S, Kappelman MD, Grossman A, Samson C, Sudel B, Oliva-Hemker M, Leleiko N, Markowitz J; Pediatric Infl ammatory Bowel Disease Collaborative Research Group Registry.

Am J Gastroenterol. 2011 May;106(5):981-7. doi: 10.1038/ajg.2010.493. Epub 2011 Jan 11.

PMID:
21224840
41.

Recognizing gastrointestinal and hepatic manifestations of primary immunodeficiency diseases.

Guerrerio AL, Frischmeyer-Guerrerio PA, Lederman HM, Oliva-Hemker M.

J Pediatr Gastroenterol Nutr. 2010 Nov;51(5):548-55. doi: 10.1097/MPG.0b013e3181efe56b. Review.

PMID:
20871412
42.

Real-time tool to display the predicted disease course and treatment response for children with Crohn's disease.

Siegel CA, Siegel LS, Hyams JS, Kugathasan S, Markowitz J, Rosh JR, Leleiko N, Mack DR, Crandall W, Evans J, Keljo DJ, Otley AR, Oliva-Hemker M, Farrior S, Langton CR, Wrobel IT, Wahbeh G, Quiros JA, Silber G, Bahar RJ, Sands BE, Dubinsky MC.

Inflamm Bowel Dis. 2011 Jan;17(1):30-8. doi: 10.1002/ibd.21386. Epub 2010 Sep 1.

43.

Factors that determine risk for surgery in pediatric patients with Crohn's disease.

Schaefer ME, Machan JT, Kawatu D, Langton CR, Markowitz J, Crandall W, Mack DR, Evans JS, Pfefferkorn MD, Griffiths AM, Otley AR, Bousvaros A, Kugathasan S, Rosh JR, Keljo DJ, Carvalho RS, Tomer G, Mamula P, Kay MH, Kerzner B, Oliva-Hemker M, Kappelman MD, Saeed SA, Hyams JS, Leleiko NS.

Clin Gastroenterol Hepatol. 2010 Sep;8(9):789-94. doi: 10.1016/j.cgh.2010.05.021. Epub 2010 May 31.

PMID:
20566311
44.

Nutritional considerations in pediatric inflammatory bowel disease.

Conklin LS, Oliva-Hemker M.

Expert Rev Gastroenterol Hepatol. 2010 Jun;4(3):305-17. doi: 10.1586/egh.10.23. Review.

PMID:
20528118
45.

Extraintestinal manifestations of pediatric inflammatory bowel disease and their relation to disease type and severity.

Dotson JL, Hyams JS, Markowitz J, LeLeiko NS, Mack DR, Evans JS, Pfefferkorn MD, Griffiths AM, Otley AR, Bousvaros A, Kugathasan S, Rosh JR, Keljo D, Carvalho RS, Tomer G, Mamula P, Kay MH, Kerzner B, Oliva-Hemker M, Langton CR, Crandall W.

J Pediatr Gastroenterol Nutr. 2010 Aug;51(2):140-5. doi: 10.1097/MPG.0b013e3181ca4db4.

PMID:
20453677
46.

Rash induced by anti-tumor necrosis factor agents in an adolescent with Crohn's disease.

Conklin LS, Cohen B, Wilson L, Cuffari C, Oliva-Hemker M.

Nat Rev Gastroenterol Hepatol. 2010 Mar;7(3):174-7. doi: 10.1038/nrgastro.2010.7.

PMID:
20203680
47.

Outcome after percutaneous endoscopic gastrostomy in children and young adults.

Fortunato JE, Troy AL, Cuffari C, Davis JE, Loza MJ, Oliva-Hemker M, Schwarz KB.

J Pediatr Gastroenterol Nutr. 2010 Apr;50(4):390-3. doi: 10.1097/MPG.0b013e3181aed6f1.

PMID:
20179645
48.

Outcome following infliximab therapy in children with ulcerative colitis.

Hyams JS, Lerer T, Griffiths A, Pfefferkorn M, Stephens M, Evans J, Otley A, Carvalho R, Mack D, Bousvaros A, Rosh J, Grossman A, Tomer G, Kay M, Crandall W, Oliva-Hemker M, Keljo D, LeLeiko N, Markowitz J; Pediatric Inflammatory Bowel Disease Collaborative Research Group.

Am J Gastroenterol. 2010 Jun;105(6):1430-6. doi: 10.1038/ajg.2009.759. Epub 2010 Jan 26.

PMID:
20104217
49.

NOD2 mutations and anti-Saccharomyces cerevisiae antibodies are risk factors for Crohn's disease in African Americans.

Dassopoulos T, Nguyen GC, Talor MV, Datta LW, Isaacs KL, Lewis JD, Gold MS, Valentine JF, Smoot DT, Harris ML, Oliva-Hemker M, Bayless TM; NIDDK IBD Genetics Consortium, Burek CL, Brant SR.

Am J Gastroenterol. 2010 Feb;105(2):378-86. doi: 10.1038/ajg.2009.575. Epub 2009 Oct 13.

50.

Retrospective Evaluation of the Safety and Effect of Adalimumab Therapy (RESEAT) in pediatric Crohn's disease.

Rosh JR, Lerer T, Markowitz J, Goli SR, Mamula P, Noe JD, Pfefferkorn MD, Kelleher KT, Griffiths AM, Kugathasan S, Keljo D, Oliva-Hemker M, Crandall W, Carvalho RS, Mack DR, Hyams JS.

Am J Gastroenterol. 2009 Dec;104(12):3042-9. doi: 10.1038/ajg.2009.493. Epub 2009 Sep 1.

PMID:
19724267

Supplemental Content

Loading ...
Support Center